Affiliation:
1. Service d'Otorhinolaryngologie et de Chirurgie Cervico‐Faciale Hôpital Européen Georges Pompidou Université Paris Cité Paris France
2. Division Head & Neck Surgery, Department of Otolaryngology Stanford University Palo Alto California U.S.A.
3. Penn Center for Head & Neck Cancer, Department of Otorhinolaryngology Head & Neck Surgery Pennsylvania University Philadelphia Pennsylvania U.S.A.
Abstract
ObjectivesThe aim of this study was to document 10‐year outcomes after supracricoid partial laryngectomy (SCPL) in selected cT3M0 laryngeal squamous cell carcinoma (SCC) patients.MethodsThis real‐life retrospective observational study analyzed an inception cohort of 168 patients with isolated, untreated, selected cT3M0 laryngeal SCC, that were consecutively managed by SCPL during the period 1973–2013, and followed up until death or for a minimum of 10 years in 92% of cases at a single French academic and tertiary referral care center. Prior induction chemotherapy, arytenoid cartilage removal, level II–IV neck dissection, and postoperative radiation therapy were performed on 148, 77, 136, and 27 patients, respectively. The main objective was to determine 10‐year actuarial local control and laryngeal preservation estimates. Secondary objectives included 10‐year actuarial survival and cause‐of‐death analysis, and assessment of correlations between endpoints and clinical variables. The significance threshold was set at p < 0.005.ResultsTen‐year actuarial local control, laryngeal preservation, and survival estimates were 90%, 85%, and 52%, respectively. Salvage treatment resulted in an overall 99% local control rate. Metachronous second primary cancer, intercurrent disease without evidence of SCC, SCPL‐related death, and uncontrolled local recurrence accounted for 31%, 26%, 7%, and 2% of causes of death. On univariate analysis, overall local recurrence and laryngeal preservation rates varied significantly, from 5% to 54% and 90% to 46% when resection margins were R0 and R1, respectively.ConclusionThe present study highlighted successful 10‐year outcomes after SCPL, providing further evidence in favor of its integration into the conservative armamentarium for endolaryngeal cT3 SCC.Level of Evidence4 Laryngoscope, 2024